Weder, Alan B <br/><br/>
ONTARGET: How much RAS inhibition is enough?  [electronic resource] 

 -  Current hypertension reports  Feb 2009 
 - 7-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1534-3111 
<br/><br/><label>Standard No.: </label>10.1007/s11906-009-0002-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Benzimidazoles--pharmacology<br/>Benzoates--pharmacology<br/>Humans<br/>Kidney Diseases--prevention & control<br/>Ramipril--pharmacology<br/>Renin-Angiotensin System--drug effects<br/>Telmisartan